Severe rhabdomyolysis complicated by respiratory and renal failure developed three weeks after initiation of low dose lovastatin therapy in a 79 year old, non-immunocompromised patient. The concomitant use of gemfibrozil may increase the risk of this complication.
No takes yet. Share an insight, caveat, or question.
Kogan et al. (1990) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: